Side effects7 min read

GLP-1 side effects, and how to ride them out

Most people on a GLP-1 notice some side effects, and most of them are digestive. The reassuring pattern from the trials and clinical experience: they tend to be worst around dose increases and to ease as the body adjusts.

Why your stomach feels different

The same slowed stomach emptying that helps you feel full also explains most side effects. Food lingers, digestion runs slower, and that can read as nausea, fullness, reflux, or constipation.

It's a predictable consequence of how the medication works — not a sign something has gone wrong.

The common ones

The side effects reported most often in GLP-1 trials are:

Nausea — the most common, usually mild to moderate.
Constipation and, for some, diarrhea.
Reflux, burping, bloating, and feeling full very quickly.
Fatigue, especially early on or after a dose step-up.

When they usually peak

Side effects tend to cluster around the first few weeks and around each dose increase, then settle as your body adapts to the new level.

If you track them in Trimm, you'll often see this pattern in your own data — and the Side effects tab can surface how a symptom lines up with your dose timing.

Everyday things many people find help

These are general comfort ideas, not medical advice — but they're low-risk and widely suggested:

Smaller portions, eaten slowly — large meals sit heavily.
Steady hydration through the day.
Easing back on very greasy or very sugary foods when symptoms flare.
Building fibre gradually to help with constipation.

When to contact your prescriber

Comfort tips are for the everyday. Some things are a conversation with a professional — promptly. Reach out for severe or persistent abdominal pain, vomiting that won't stop, signs of dehydration, or anything that frightens you.

Your prescriber can also adjust the pace of your titration if side effects are too much. That's a normal, expected part of treatment — not a failure.

The short version

Most GLP-1 side effects are digestive and tend to ease with time.
They usually peak around dose increases.
Smaller meals, hydration, and gradual fibre are common comfort steps.
Severe or persistent symptoms warrant a prompt call to your prescriber.

Sources

1.Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine (2021).Reported gastrointestinal adverse events and their time course.
2.Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine (2022).Adverse-event profile, mostly mild-to-moderate and gastrointestinal.
3.U.S. FDA Prescribing Information for semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro).Approved indications, titration schedules, and reported adverse events.

This is general education, not medical advice. It can't account for your individual history — decisions about your medication, dose, and care belong with you and your prescriber.